(NASDAQ: SEER) Seer's forecast annual revenue growth rate of 28.57% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 34.98%, and while it is forecast to beat the US market's average forecast revenue growth rate of 9.26%.
Seer's revenue in 2024 is $14,738,000.On average, 2 Wall Street analysts forecast SEER's revenue for 2024 to be $857,366,549, with the lowest SEER revenue forecast at $856,936,545, and the highest SEER revenue forecast at $857,796,553. On average, 2 Wall Street analysts forecast SEER's revenue for 2025 to be $1,306,720,730, with the lowest SEER revenue forecast at $1,296,154,917, and the highest SEER revenue forecast at $1,317,347,972.
In 2026, SEER is forecast to generate $1,957,808,217 in revenue, with the lowest revenue forecast at $1,855,282,977 and the highest revenue forecast at $2,060,333,456.